ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38530; 2) Community: the network communities that were significantly associated with the response to NSC 38530; 3) Molecule: the relationships between components within communities and NSC 38530; 4) MDR: the compounds that were significantly associated with the NSC 38530.

NSC Compound Enrichment Correlation
NSC 685272 D-Glucose, [4-[(4-chlorophenyl)methylene]-5-oxo- 2-imidazolidinylidene]hydrazone 0.024108502230778 -0.019907893
NSC 700203 Null 0.024108502230778 0.38097937
NSC 70811 Null 0.024108502230778 -0.32335093
NSC 720860 3,3'-dimethoxycarbonyl-5,5'-dimethyl-N,N-Bis(pyrazol-1-yl methyl)aniline 0.024108502230778 0.43019479
NSC 724601 S-(dimethylarsino)-3-mercapto-1,2-propyl dinonanoate 0.024108502230778 0.60773592
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.024108502230778 0.20141498
NSC 736200 6-(3-Bromopropyl)-5,6-dihydro3-nitro-5,11-dioxo-9-thiomethyl -11H-indeno[1,2-c]isoquinoline 0.024108502230778 0.039752275
NSC 758664 Sirolimus [USAN] 0.024108502230778 -0.34352362
NSC 94600 Camptothecin 0.024108502230778 0.0046832182
NSC 1393 4-APP 0.0241085022307781 0.31098607
Total:84  Current:45    [First] [Prev] [Next] [Last]